Overview

GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to analyze the effectiveness of GnRh antagonist in the treatment of early ovarian hyperstimulation syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Treatments:
Cetrorelix
Pharmaceutical Solutions